PPM1A facilitates both nuclear distribution and transcription potency of YAP/TAZ. by Ruyuan Zhou (10197187)

“…<b>(B–D)</b> Transcription potency of YAP (5 ng), which was suppressed by coexpression of MST1 (50 ng) (B), LATS1 (500 ng) (C), or MAP4K1 (50 ng) (D), was markedly recovered by cotransfection of wild-type PPM1A but not the enzyme-dead PPM1A (D239N). …”

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

TA1 results in a decreased <i>in vivo</i> inflammatory response upon allogeneic cells challenge. by Duncheng Wang (838084)

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”

(A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells by Masakatsu Yamashita (46657)

“…MeDIP assay was performed using an anti–5-methyl cytidine antibody (5-meC) and a control antibody (Cont.). …”

In primary cultures of differentiated subcutaneous (a) and omental (b) pre-adipocytes, Dex decreases lipogenesis in the absence of insulin. by Laura L. Gathercole (341979)

Effect of hydrogen peroxide on cellular viability in BSO-treated cells. by Takeo Edamatsu (4885138)

Functional metabolism pathways present at ≥ 0.5% mean relative abundance in Control calves (n = 15) and High-Se treatment calves (n = 15) after weaning (baseline; week 0), at the e... by Jean A. Hall (289030)

PGC-1β KO mice show a specific decrease in Mfn2 expression in skeletal muscle. by Marc Liesa (35879)

Pharmacological inhibition of Hsp90 with GdA decreased apoptosis and caspase activity of <i>C. albicans.</i> by BaoDi Dai (307154)

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…In the contralateral (unlesioned) hemisphere (CL), no difference was seen in the proportion of axons in the corpus callosum that were myelinated in Scribble cKO compared to wild-type animals (A–C). Fewer remyelinated axons were observed in corpus callosum in the lesion area in Scribble cKO mice (E) relative to controls (D) as quantified in F; 0.4–0.5 μm: WT = 80.0% ± 9.8%, cKO = 41.3% ± 8.9% myelinated; 0.5–0.6 μm: WT = 79.4% ± 6.3%, cKO = 41.5% ± 9.5% myelinated; 0.6–0.7 μm: WT = 91.6% ± 3.0%, cKO = 44.3% ± 8.7% myelinated; >0.7 μm: WT = 92.7% ± 1.9%, cKO = 47.9% ± 2.5% myelinated. …”

Astrocytes express a ligand for NKp44 and increasing concentrations of HIV 3S peptide decreases its expression. by Kelly E. Bowen (4857370)

Time course of the variances (<i>V</i>_<i>ip</i>, <i>V</i>_<i>g</i>) after switching interaction strength. by Naoto Nishiura (11668953)

“…The two variances of the non-target output genes decrease, while <i>V</i>_<i>g</i> < <i>V</i>_<i>ip</i> is maintained throughout the evolutionary course (a). …”

Decreased IFNγ production by Ly49H⁺ NK cells in A/J mice. by Nassima Fodil (669326)

Visual abstract for "The impact of concession patterns on negotiations: When and why decreasing concessions lead to a distributive disadvantage" by Michael SCHAERER (8645940)

“…Finally, we find that recipients can protect themselves against the deleterious effects of decreasing concession by thinking of a target before they enter the negotiation (Study 5).…”

Ephrin-A2 and –A6 expression and EphA4 Tyr-602 phosphorylation decrease from nasal to temporal RGCs. by Ana Laura Ortalli (159899)

The numbers of parasite cysts in the brain decrease and the sizes increase as <i>Toxoplasma gondii</i> infection progresses in mice C57BL/6. by Leda Castaño Barrios (8524317)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

The ability of KLK6 to decrease death of murine splenocytes relates to its ability to delay the apoptotic cascade. by Isobel A. Scarisbrick (354022)